UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.985

Sortiert nach

Peripheral-Track and Central-Track Hill-Sachs Lesions: A New Concept of Assessing an On-Track Lesion

The American journal of sports medicine, 2020-01, Vol.48 (1), p.33-38

2020

Link zum Volltext

Verfügbarkeit prüfen

LUX-Lung 4: A Phase II Trial of Afatinib in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or Both

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3335-3341

2013

Link zum Volltext

Verfügbarkeit prüfen

Catalytic Atroposelective Synthesis of N‑Aryl Quinoid Compounds

Journal of the American Chemical Society, 2020-02, Vol.142 (5), p.2198-2203

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

The lancet oncology, 2015-07, Vol.16 (7), p.830-838

2015

Link zum Volltext

Verfügbarkeit prüfen

Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L

Cancer science, 2022-01, Vol.113 (1), p.221-228

2022

Link zum Volltext

Verfügbarkeit prüfen

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

International journal of clinical oncology, 2019-07, Vol.24 (7), p.731-770

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of gefitinib for non‐adenocarcinoma non‐small‐cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports

Cancer science, 2011-05, Vol.102 (5), p.1032-1037

2011

Link zum Volltext

Verfügbarkeit prüfen

Contact between the glenoid and the humeral head in abduction, external rotation, and horizontal extension: A new concept of glenoid track

Journal of shoulder and elbow surgery, 2007-09, Vol.16 (5), p.649-656

2007

Link zum Volltext

Verfügbarkeit prüfen

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

The lancet oncology, 2015-02, Vol.16 (2), p.141-151

2015

Link zum Volltext

Verfügbarkeit prüfen

Critical shoulder angle in an East Asian population: correlation to the incidence of rotator cuff tear and glenohumeral osteoarthritis

Journal of shoulder and elbow surgery, 2018-09, Vol.27 (9), p.1602-1606

2018

Link zum Volltext

Verfügbarkeit prüfen

Measurement of the Glenoid Track In Vivo as Investigated by 3-Dimensional Motion Analysis Using Open MRI

The American journal of sports medicine, 2014-06, Vol.42 (6), p.1290-1295

2014

Link zum Volltext

Verfügbarkeit prüfen

CH5424802 (RO5424802) for patients with ALK -rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study

The lancet oncology, 2013-06, Vol.14 (7), p.590-598

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2020-07, Vol.38 (19), p.2187-2196

2020

Link zum Volltext

Verfügbarkeit prüfen

Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3342-3350

2013

Link zum Volltext

Verfügbarkeit prüfen

Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody

Cancer Immunology, Immunotherapy, 2020, Vol.69 (1), p.15-22

2020

Link zum Volltext

Verfügbarkeit prüfen

Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2018-07, Vol.121, p.37-40

2018

Link zum Volltext

Verfügbarkeit prüfen

Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3

Cancer science, 2015-09, Vol.106 (9), p.1202-1211

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3739-3745

2010

Link zum Volltext

Verfügbarkeit prüfen

Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2020-01, Vol.139, p.195-199

2020

Link zum Volltext

Verfügbarkeit prüfen

In Which Arm Position Is a Hill-Sachs Lesion Created?

The American journal of sports medicine, 2019-08, Vol.47 (10), p.2464-2468

2019

Link zum Volltext

Verfügbarkeit prüfen

Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan

International journal of clinical oncology, 2015-10, Vol.20 (5), p.855-865

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 3.985

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.165)
Mit Volltextzugriff
(3.728)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Peripheral-Track and Central-Track Hill-Sachs Lesions: A New Concept of Assessing an On-Track Lesion

LUX-Lung 4: A Phase II Trial of Afatinib in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or Both

Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study

Catalytic Atroposelective Synthesis of N‑Aryl Quinoid Compounds

Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6

Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial

Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Efficacy of gefitinib for non‐adenocarcinoma non‐small‐cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports

Contact between the glenoid and the humeral head in abduction, external rotation, and horizontal extension: A new concept of glenoid track

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

Critical shoulder angle in an East Asian population: correlation to the incidence of rotator cuff tear and glenohumeral osteoarthritis

Measurement of the Glenoid Track In Vivo as Investigated by 3-Dimensional Motion Analysis Using Open MRI

CH5424802 (RO5424802) for patients with ALK -rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study

Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer

Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations

Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody

Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3

Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105

Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

In Which Arm Position Is a Hill-Sachs Lesion Created?

Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan

Suchergebnisse filtern